MR Contrast Agents: What Is Their Value?

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

MR Contrast Agents: What Is Their Value? 
Thursday, Dec. 2, 3:00 – 4:00 PM

This session is examining the cases for and against Gd-EOB-DTPA and Gadofosveset and offering insights into Gadobutrol. Speakers also are presenting on-label applications, off-label possibilities and opportunities for using new agents in clinical practice.

Speaker information:

  • Elmar Merkle, MD, department of radiology, Duke University in Durham, N.C.; and
  • Neil Mitchell Rofsky, MD, chief, MRI, Beth Israel Deaconess Medical Center in Boston.